FPR2 agonists exert cardioprotection by resolving inflammatory signalling in macrophages, not cardiomyocytes or cardiac fibroblasts

28 August 2026 (12:24 - 12:36)
Organised by: Logo
Congress Presentation Part of: Macrophage biology and inflammation in cardiovascular disease Drugs, Drug Targets ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology